Beatrice Drambarean

After the publication of the article [1] it was noted that the article’s Competing interests statement was incorrect. The Competing interests statement was initially correct in the original submission but due to a misunderstanding and an error during a technical check, part of the statement was removed during an update to the statement.

Ferric carboxymaltose Ferric carboxymaltose is not FDA approved in dialysis patients.18 However, its use was trialed in 50 non-pregnant hemodialysis patients and shown to be equally well tolerated and effective as compared to standard care.19 A 2019 study in which 100 pregnant women not on dialysis were randomized to receive either iron sucrose or ferric carboxymaltose, demonstrated that ferric carboxymaltose was non-inferior to iron sucrose, and more rapidly replenished iron stores over a...